ArticleClinical rheumatology2026
Impaired telomere maintenance in rheumatoid arthritis: a case-control study of telomerase reverse transcriptase and telomeric repeat-binding factors in disease susceptibility and functional impairment.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesTo determine the association of telomere-associated proteins, including telomerase reverse transcriptase (TERT), telomeric repeat-binding factor 1 (TERF1), and telomeric repeat-binding factor 2 (TERF2), with rheumatoid arthritis (RA) susceptibility, disease activity, and functional impairment.
methodsThis case-control study was conducted from March 2025 to February 2026 at the Department of Biochemistry, Islamic International Medical College, Riphah International University, Islamabad, in collaboration with Foundation University, Islamabad, and the Rheumatology Department of a Fauji Foundation Hospital, Rawalpindi. A non-probability purposive sampling technique was used to enroll 66 female patients with RA diagnosed according to the American College of Rheumatology (ACR) classification criteria and 22 age-matched healthy female controls. Disease activity and functional status were assessed using the Clinical Disease Activity Index (CDAI) and Modified Health Assessment Questionnaire (MHAQ). Serum levels of TERT, TERF1, and TERF2 were measured using enzyme-linked immunosorbent assay. Statistical analysis, including group comparisons, correlation, linear regression, binary logistic regression, and mediation analysis, was performed using SPSS version 21.
resultsBinary logistic regression analysis demonstrated that TERT (OR = 7.35, 95% CI, 1.63-33.15, p = 0.009) and TERF2 (OR = 11.04, 95% CI, 2.68-45.50, p = 0.001) were significantly associated with RA susceptibility. Correlation analysis showed weak and non-significant associations of TERT and TERF2 with disease activity and functional disability (r = - 0.011, p = 0.929) (r = 0.175, p = 0.163) and functional disability (r = - 0.011, p = 0.930) (r = 0.092, p = 0.466) respectively. Linear regression analysis demonstrated that TERF1 was significantly associated with functional disability (B = 0.771, p = 0.025). Mediation analysis indicated that TERF1 was not significantly associated with disease activity (B = 5.764, p = 0.326), while disease activity was significantly associated with functional disability (B = 0.019, p = 0.0069), and the indirect effect was not statistically significant (bootstrap 95% confidence interval, - 0.066 to 0.363).
conclusionsTERT and TERF2 were significantly associated with RA susceptibility, whereas TERF1 may influence functional impairment through mechanisms independent of inflammatory disease activity. These findings highlight the potential role of telomere-associated proteins in the pathogenesis and clinical heterogeneity of RA. Key Points • Telomerase reverse transcriptase (TERT) and telomeric repeat-binding factor 2 (TERF2) were associated with rheumatoid arthritis susceptibility. • Telomeric repeat-binding factor 1 (TERF1) was identified as a predictor of functional impairment in rheumatoid arthritis. • Functional disability may be influenced by inflammation-independent mechanisms rather than disease activity alone. • Telomere regulatory pathways may contribute to both disease development and progression in rheumatoid arthritis.
Indexed as
Identifiers
42771105What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.